New Drug May Help Relieve Long-term Cough, Early Trial Suggests New Drug May Help Relieve Long-term Cough, Early Trial Suggests

Gefapixant shows promise in a phase 2b trial for a condition that affects 4% to 10% of adults worldwide and has had no safe, long-term treatments available.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Pulmonary Medicine News Source Type: news